# Avalor Therapeutics, Inc. — Form D

Avalor Therapeutics, Inc. of Kenmore, WA, a company, filed a Form D exempt-offering notice with the SEC on 2023-12-05. The offering totals $800K, of which $335K was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2023-12-05
- Form: D
- Accession: 0001994868-23-000002
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $800K
- Amount sold: $335K
- Remaining: $465K
- Minimum investment: $25K
- Investors: 6
- Date of first sale: 2023-08-01
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-498811

## Issuer

- Name: Avalor Therapeutics, Inc.
- CIK: 0001994868
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2020
- Address: 6700 NE 181st St., #82506, Kenmore, WA, 98028
- Phone: 8056376529

## Officers, directors & promoters (4)

| Name | Role | Location |
| --- | --- | --- |
| Anthony E Ford | Director | Kenmore, WA |
| William E Martinez Zegarra | Director | Kenmore, WA |
| Kenneth E Wild | Director | Kenmore, WA |
| William E Martinez Zegarra | Executive Officer | Kenmore, WA |

## More

- [CIK 1994868 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1994868&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001994868-23-000002.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.